RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 45-55
  • AstraZeneca boosted by start of new cancer drug trial

    LONDON (Reuters) - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer. The drug, which is designed to help the...
  • Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

    (Reuters) - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S....
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...
  • Baruch Blumberg dies at 85; Nobel Prize winner who discovered hepatitis B virus

    Baruch Blumberg dies at 85; Nobel Prize winner who discovered hepatitis B virus
    Dr. Baruch Blumberg, who received the 1976 Nobel Prize in physiology or medicine for discovering the hepatitis B virus, which causes severe liver disease and cancer, and who later developed the vaccine that protects against it, has died. He was 85....
  • Dick Clark dies at 82; he introduced America to rock 'n' roll

    Dick Clark dies at 82; he introduced America to rock 'n' roll
    Dick Clark, the youthful-looking television personality who literally introduced rock 'n' roll to much of the nation on "American Bandstand" and for four decades was the first and last voice many Americans heard each year with his New Year's Eve...
  • Charles Farthing dies at 60; doctor at forefront of AIDS care

    Charles Farthing dies at 60; doctor at forefront of AIDS care
    Charles F. Farthing, a physician who was at the forefront of care for HIV/AIDS patients and who drew attention to the need for an AIDS vaccine by announcing his willingness to inject himself, has died. He was 60. Farthing, who collapsed in a Hong Kong...
  • Alexander Shulgin, chemist behind MDMA, dies at 88

     Alexander Shulgin, chemist behind MDMA, dies at 88
    Biochemist Alexander Shulgin accidentally discovered one of the most famous and infamous party drugs of the 1980s. He synthesized a compound called MDMA in 1976 in his backyard laboratory and, as was his tradition, tried it out on himself. "First...
  • Joe South dies at 72; singer-songwriter did 'Games People Play'

    Joe South dies at 72; singer-songwriter did 'Games People Play'
    Joe South, a versatile singer-songwriter who penned "Games People Play," "Down in the Boondocks" and other pop-rock hits in the 1960s and '70s, has died. He was 72. South died Wednesday at his home in Buford, Ga., northeast of Atlanta, said Butch Lowery,...
  • EU regulator warns on possible MS drugs side effects

    FRANKFURT (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs. A...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • Achillion's hepatitis C drug shows promise in trial

    (Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. The mid-stage trial tested Achillion's...